These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35563111)

  • 1. Cytotoxicity of Newly Synthesized Quinazoline-Sulfonamide Derivatives in Human Leukemia Cell Lines and Their Effect on Hematopoiesis in Zebrafish Embryos.
    Alqahtani AS; Ghorab MM; Nasr FA; Ahmed MZ; Al Mishari AA; Attia SM; Farooq Khan M
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Antiproliferative and Apoptotic Effects of a Novel Quinazoline Carrying Substituted-Sulfonamides: In Vitro and Molecular Docking Study.
    Alqahtani AS; Ghorab MM; Nasr FA; Ahmed MZ; Al-Mishari AA; Attia SM
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of Novel Class of N-Alkyl-isatin-3-iminobenzoic Acid Derivatives and Their Biological Activity in Zebrafish Embryos and Human Cancer Cell Lines.
    Farooq M; Al Marhoon ZM; Taha NA; Baabbad AA; Al-Wadaan MA; El-Faham A
    Biol Pharm Bull; 2018 Mar; 41(3):350-359. PubMed ID: 29249771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinazoline sulfonamide derivatives targeting MicroRNA-34a/MDM4/p53 apoptotic axis with radiosensitizing activity.
    Soliman AM; Kodous AS; Al-Sherif DA; Ghorab MM
    Future Med Chem; 2024; 16(10):929-948. PubMed ID: 38661115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of mono-and di-pyrazolyl-s-triazine derivatives, their anticancer profile in human cancer cell lines, and in vivo toxicity in zebrafish embryos.
    Farooq M; Sharma A; Almarhoon Z; Al-Dhfyan A; El-Faham A; Taha NA; Wadaan MAM; Torre BG; Albericio F
    Bioorg Chem; 2019 Jun; 87():457-464. PubMed ID: 30927586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dinuclear Ru
    Lenis-Rojas OA; Roma-Rodrigues C; Fernandes AR; Marques F; Pérez-Fernández D; Guerra-Varela J; Sánchez L; Vázquez-García D; López-Torres M; Fernández A; Fernández JJ
    Inorg Chem; 2017 Jun; 56(12):7127-7144. PubMed ID: 28585811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [1,2,4]Triazolo[4,3-c]quinazoline and bis([1,2,4]triazolo)[4,3-a:4',3'-c]quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies.
    El-Adl K; Ibrahim MK; Alesawy MSI; Eissa IH
    Bioorg Med Chem; 2021 Jan; 30():115958. PubMed ID: 33360576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity, multitarget mechanisms, and molecular docking studies of quinazoline derivatives based on a benzenesulfonamide scaffold: Cell cycle analysis.
    El-Azab AS; Abdel-Aziz AA; AlSaif NA; Alkahtani HM; Alanazi MM; Obaidullah AJ; Eskandrani RO; Alharbi A
    Bioorg Chem; 2020 Nov; 104():104345. PubMed ID: 33142413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Thiourea Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Through COX-2 Inhibition.
    Ghorab MM; El-Gaby MSA; Alsaid MS; Elshaier YAMM; Soliman AM; El-Senduny FF; Badria FA; Sherif AYA
    Anticancer Agents Med Chem; 2017; 17(10):1411-1425. PubMed ID: 28356021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, One Pot Synthesis and Molecular Docking Studies of Substituted-1H-Pyrido[2,1-b] Quinazolines as Apoptosis-Inducing Anticancer Agents.
    Bathula R; Satla SR; Kyatham R; Gangarapu K
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):411-421. PubMed ID: 32102519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinazoline-sulfonamides as potential antitumor agents: synthesis and biological testing.
    Alafeefy AM; Alqasoumi SI; Ashour AE; Alshebly MM
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):375-83. PubMed ID: 22468752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Novel Quinazoline Derivatives as Potent Antitumor Agents.
    Niu Z; Ma S; Zhang L; Liu Q; Zhang S
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35745027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, anticancer evaluation and molecular docking studies of new heterocycles linked to sulfonamide moiety as novel human topoisomerase types I and II poisons.
    Halawa AH; Elgammal WE; Hassan SM; Hassan AH; Nassar HS; Ebrahim HY; Mehany ABM; El-Agrody AM
    Bioorg Chem; 2020 May; 98():103725. PubMed ID: 32199303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
    Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
    Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and antitumor activity evaluation of novel acyl sulfonamide spirodienones.
    Chen C; Luo Y; Yin H; Zhong Q; Zheng S; Liu R; Zhao C; Wang G; He L
    Bioorg Med Chem; 2022 Apr; 60():116626. PubMed ID: 35255412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual EGFR/HER2 inhibitors and apoptosis inducers: New benzo[g]quinazoline derivatives bearing benzenesulfonamide as anticancer and radiosensitizers.
    Ghorab MM; Alsaid MS; Soliman AM
    Bioorg Chem; 2018 Oct; 80():611-620. PubMed ID: 30041137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents.
    Ahmed EY; Abdel Latif NA; El-Mansy MF; Elserwy WS; Abdelhafez OM
    Bioorg Med Chem; 2020 Mar; 28(5):115328. PubMed ID: 31992477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives.
    Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; Zahran SS
    Eur J Med Chem; 2015 Mar; 92():682-92. PubMed ID: 25618015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel quinazoline-sulfonamides as anti-cancer agents.
    Poudapally S; Battu S; Velatooru LR; Bethu MS; Janapala VR; Sharma S; Sen S; Pottabathini N; Iska VBR; Katangoor V
    Bioorg Med Chem Lett; 2017 May; 27(9):1923-1928. PubMed ID: 28351589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, cytotoxic evaluation, and molecular docking studies of novel quinazoline derivatives with benzenesulfonamide and anilide tails: Dual inhibitors of EGFR/HER2.
    Alkahtani HM; Abdalla AN; Obaidullah AJ; Alanazi MM; Almehizia AA; Alanazi MG; Ahmed AY; Alwassil OI; Darwish HW; Abdel-Aziz AA; El-Azab AS
    Bioorg Chem; 2020 Jan; 95():103461. PubMed ID: 31838290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.